ID: ALA2147289

Max Phase: Preclinical

Molecular Formula: C41H35FN4O4

Molecular Weight: 666.75

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOc1ccc(-c2ccccc2C(=O)Nc2ccc3cc(C(=O)N[C@H](C(=O)N(C)Cc4ccc(F)cc4)c4ccccc4)ccc3n2)cc1

Standard InChI:  InChI=1S/C41H35FN4O4/c1-3-50-33-21-15-28(16-22-33)34-11-7-8-12-35(34)40(48)44-37-24-18-30-25-31(17-23-36(30)43-37)39(47)45-38(29-9-5-4-6-10-29)41(49)46(2)26-27-13-19-32(42)20-14-27/h4-25,38H,3,26H2,1-2H3,(H,45,47)(H,43,44,48)/t38-/m0/s1

Standard InChI Key:  LZGBUQAWWBRUQV-LHEWISCISA-N

Associated Targets(Human)

Microsomal triglyceride transfer protein large subunit 242 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 666.75Molecular Weight (Monoisotopic): 666.2642AlogP: 7.82#Rotatable Bonds: 11
Polar Surface Area: 100.63Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 1.68CX LogP: 7.66CX LogD: 7.66
Aromatic Rings: 6Heavy Atoms: 50QED Weighted: 0.15Np Likeness Score: -1.37

References

1. Robinson RP, Bartlett JA, Bertinato P, Bessire AJ, Cosgrove J, Foley PM, Manion TB, Minich ML, Ramos B, Reese MR, Schmahai TJ, Swick AG, Tess DA, Vaz A, Wolford A..  (2011)  Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.,  21  (14): [PMID:21684740] [10.1016/j.bmcl.2011.05.099]

Source